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Background: In joint prosthetic surgery, various methods are used to provide implant stability. We used an
injectable bone substitute, composed of calcium sulfate/hydroxyapatite, as bone defect filler to stabilize a tibia
prosthesis in an experimental rabbit model. The aim of the study was to investigate and compare the stability of
prosthetic fixation with and without the use of an injectable bone substitute.
Methods: Sixteen rabbits were used and the tibia prostheses were implanted bilaterally, one side with the
prosthesis alone and the other side with the prosthesis and calcium sulfate/hydroxyapatite (Cerament™). The rabbits
were randomly divided into two groups and euthanized after 6 and 12 weeks, respectively. The prosthesis was
extracted measuring the pull-out force in an Instron tester, and the bone surrounding the former prosthesis site
was analyzed by histology, histomorphometry, and micro-computed tomography.
Results: At 6 weeks no difference in maximum pull-out force was found between the prostheses fixed with or
without Cerament™. At 12 weeks the maximum pull-out force for the prostheses with Cerament™ was significantly
higher than that for the prostheses without Cerament™ (p = 0.04). The maximum pull-out force at 12 weeks was
significantly higher than that at 6 weeks for the prostheses fixed with Cerament™ (p = 0.03) but not for the
prostheses without.
Conclusion: We conclude that early prosthesis-bone interface strength is not influenced by a bone substitute.
However, during remodeling, the bone substitute might provide improved mechanical support for the prosthesis.
The results support further studies of the use of injectable calcium sulfate/hydroxyapatite in fixation of prosthetic
joint implants.
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The gold standard for restoring bone defects is still con-
sidered to be autologous bone graft. Limitations exist,
especially regarding donor site morbidity and a limited
supply. In primary and revision arthroplasties, alterna-
tives include allografts, bone cement, or the use of long-
stemmed prostheses [1,2]. By using allograft bone, a
potential risk for blood-borne diseases such as hepatitis
and HIV is introduced. Alternatives have been tried* Correspondence: Vasileios.Zampelis@med.lu.se
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reproduction in any medium, provided the orusing artificial bone grafts in the form of pellets, alone
or mixed with a bone graft [3]. Several types of inject-
able bone graft substitutes have been developed to fill
bone defects in fractures and osteotomies [4]. The
choice and composition of the artificial bone graft ma-
terial determine the mechanical properties of the bone
substitute, not only immediately after implantation but
also during the whole remodeling period. If the material
is resorbed too rapidly, the strength might be hampered
with insufficient bone support for the prosthesis. If the
material is remodeling too slowly, living new bone will
not be able to replace the bone substitute in order to se-
cure long-term fixation. Thus, a properly chosen bone
substitute or graft should be used to reconstruct boneal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and





Figure 1 The rabbit tibia prosthesis. The prosthesis stem is made
of titanium, has a 3.5-mm diameter and 8-mm length, and is not
side specific. The tibia tray can be removed and replaced by a hook
for mechanical pull-out test.
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the whole remodeling period. The selection of an appro-
priate bone graft is influenced by the size of the bone
defect, the biological prerequisites of the bone graft site,
and whether the graft is required for structural support.
We hypothesized that an injectable bone substitute
can be used to fill the gap between the bone and the
prosthesis and that combining a slowly and a fast
resorbing material into one can utilize the benefits of
the properties of the two materials, providing improved
fixation of a prosthesis. In the present study, we used
injectable calcium sulfate/hydroxyapatite bone subs-
titute [5,6] containing (1) a fast-resorbing calcium
sulfate, allowing for a fast replacement of the bone
substitute with new-forming bone [7], and (2) a hy-
droxyapatite component acting as a long-term osteo
conductive matrix embedded into the forming bone tis-
sue [8,9], providing mechanical support for the pros-
thesis during remodeling. We evaluate this biphasic
material in a primary tibia prosthesis model in rabbits,
a model previously used to study morsellized bone graft
[10]. The aim of the study was to investigate and com-
pare the stability of prosthetic fixation with and with-




Sixteen 6-month-old New Zealand white rabbits were
used. Twelve of the 16 rabbits were used for the mech-
anical testing and histological analysis, while 4 rabbits
were used for computed tomography (CT) analysis. The
rabbits were skeletally mature (weight 4.0 to 4.5 kg) and
had free access to food and water. The animals arrived
at the laboratory 1 week prior to the operation to
acclimatize. All animal procedures were carried out
according to the institutional guidelines and were ap-
proved by the ethic animal research committee (M134-
10) at the Skåne University Hospital, Lund, Sweden.
Bone substitute material
The injectable bone substitute Cerament™ (Bone Support
AB, Lund, Sweden) was used consisting of 60% calcium
sulfate and 40% hydroxyapatite (HA) [5,11]. The ratio
results in a mixture with compressive strength (wet) of
5–8 MPa, comparable to trabecular bone. The HA is of
medical grade and tested according to American stand-
ard (ASTM F1185). The bone substitute powder is
mixed with iohexol (180 mg I/ml), a low-osmolarity
nonionic iodinated contrast agent to form an injectable
paste. The working time and injectability of the sub-
stance is 6 min using a 16G cannula, and the final set-
ting time is 15 to 20 min. The maximum setting
temperature is 38°C.Surgical protocol
A rabbit tibia prosthesis has been designed for this
model [10]. It is manufactured in one size and identical
for left and right knees (manufactured by the Dept. of
Medical Technique in Lund University Hospital, Lund,
Sweden). The stem is round, 3.5 mm in diameter, and 8
mm long. A tibia plate, mimicking the tibia plateau
shape, was mounted on the top of the stem and fixed
with a screw (Figure 1). A rubber plug (4 mm in diam-
eter) was placed distally to the prosthesis to prevent ma-
terial leaking into the distal part of the bone marrow
cavity. Prior to surgery, a protocol was made of random
insertion of the prostheses with or without bone substi-
tute in the left and right tibiae. For each time point (6
and 12 weeks), six rabbits were used respectively, and
the sample size was based on the results and standard
deviations of previous studies using this model [10,12].
The rabbits were anesthetized with subcutaneous
Hypnorm® (fentanyl/fluanisone, 0.3 ml/kg) and in-
tramuscular Stesolid® (diazepam, 2.5 mg/kg). All rabbits
received a single intramuscular dose of 0.4 ml Strep
tocillin® (hydrostreptomycin and benzylpenicillin) 10
min before operation. Prior to surgery, the skin was
shaved and washed with iodine. Both tibiae were oper-
ated on. Under aseptic conditions, a midline skin inci-
sion was made over the knee joint and the joint was
approached through a medial parapatellar incision. The
patella was mobilized laterally, the menisci removed, and
a 1.5-mm area of the tibia articular surface resected with
an electric saw. The bone marrow cavity was opened
with an awl and reamed with a 3.6-mm drill. Cerament™
bone graft substitute was used for fixation of the tibia
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87 μl of iohexol, which in turn generated a liquid and
powder ratio of 0.43 ml/g. The material was mixed for 3
min in a Petri dish and inserted into the tibia cavity.
The prosthesis was gently inserted in the tibia marrow
cavity by digital pressure and thereafter gently tapped
into the bone using a mallet (Additional file 1). In the
contralateral control side, the bone marrow cavity was
simply washed with saline after reaming and the pros-
thesis implanted. Joint stability and range of motion
were controlled, and the joint capsule and the subcu-
taneous tissues were closed in two separate layers. After
surgery, the animals were allowed to move freely in their
cages. The animals were randomly divided into two
groups to be sacrificed 6 or 12 weeks after prosthetic
implantation. The animals were sacrificed by an over-
dose of pentobarbital, and six specimens in each of the
6-week and 12-week groups were randomly selected for
a pull-out test and two specimens for a micro-CT
analysis. The specimens from the pull-out tests were
subsequently fixed in formalin for histology and
histomorphometric assessment.
Pull-out test
The tibias with the prosthesis implant were cleansed
from soft tissue, and the distal parts were fixed with
bone cement in a plastic tube and mounted on an
Instron 8511 load frame with an MTS TestStar II con-
troller (Canton, MA, USA). The prosthetic tibia plate
was unscrewed and replaced by a hook screwed onto
the stem (Additional file 2). The implant was first
preloaded up to 1 N, and thereafter, the pull-out test
was performed under displacement control at 2 mm/min,
with the tester being unaware of group belonging of the
specimen. The peak force was recorded and the data from
the pull-out test were compared for the prostheses with
and without Cerament™ at 6- and 12-week time points,
respectively.
Histological and histomorphometric analyses
After the pull-out test, the same specimens were pre-
pared for histological analysis. The specimens wereFigure 2 Micro-CT regions of interest. (A) 5.25 mm was analyzed by dra
BV/TV, the volume of the prosthesis was subtracted.decalcified (10% EDTA), embedded in paraffin, cut into
5-μm sections, and stained with hematoxylin and eosin.
The specimens were cut longitudinally in 300-μm in-
tervals, and five sections were obtained from each speci-
men. The surface area of the material remaining in the
bone defect as well as the bone integration measured as
the percentage of the interface and ingrowth was analyzed
using a light microscope (Olympus Bx50, Shinjuku-ku,
Japan) and an image analysis system (Aperio Image Scope
v.11.12-752, Vista, CA, USA). The newly formed bone was
marked in the histology images, and the total bone inter-
face length was measured. The percentage of bone contact
for each specimen in all five sections was calculated. The
areas on the bottom part of the prosthesis were not in-
cluded in the measuring process since tissue had detached
in some specimens during the pull-out test. The percent-
age of bone contact was calculated as the bone contact
length divided by the total prosthesis length.
Micro-computed tomography
Four of the rabbits, two from each period (6 and 12
weeks), were evaluated with micro-CT. The proximal
tibiae were scanned with an isotropic voxel size of 35
μm (SkyScan 1172, v. 1.5, SkyScan, Aartselaar, Belgium)
at the energy settings of 100 kV and 100 μA, using an
aluminum filter of 0.5 mm, and ten repeated scans. The
images were reconstructed using NRecon (v 1.5.1.4,
SkyScan, Aartselaar, Belgium) by correcting for ring ar-
tifacts and beam hardening. Calibration of bone mineral
density (BMD) was carried out according to the system
manufacturer's protocol by scanning of a water phan-
tom and two hydroxyapatite phantoms of known den-
sity (0.25 and 0.75 g/cm3). Mineralized bone tissue was
assumed to have a BMD over 0.60 g/cm3, resulting in
gray-scale values of 88–255. A circular region of inter-
est was defined as the 1-mm outline of the circumfer-
ence of the prosthesis. Thus, a region with a total of 5.5
mm in diameter was analyzed in which the 3.5 mm of
the prosthesis cavity area was included. The length of
the prosthesis was analyzed for 5.25 mm (150 images,
Figure 2). Bone volume fraction (BV/TV) was calculated
after subtracting the volume of the implant from thewing a (B) 5.5-mm circular region of interest. Before calculating the
Table 1 Comparison of maximum pull-out force for the prostheses fixed with and without Cerament™
Maximum pull-out force (N) p value
6 weeks 12 weeks
(N = 6) (N = 5)
Median (IQR)a Median (IQR)a
Prostheses without Cerament™ 143 (78–179) 175 (115–230) 0.20
Prostheses with Cerament™ 156 (99–210) 234 (195–243) 0.03
p value 0.92 0.04


















Figure 3 Histology slides of the bone interface. Histology slides of the bone interface in the prosthesis fixed without Cerament™ (A, B) and with
Cerament™ (C, D) at week 6, and in the prosthesis fixed without Cerament™ (E, F) and with Cerament™ (G, H) at week 12 (original magnification ×1
and ×20, respectively). IA, implant position before removal; IF, interface area between the graft and the host; HA, hydroxyapatite particles integrated
with new-formed trabecular bone.
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Aartselaar, Belgium).
Statistical analysis
We have used a sample size of 12 rabbits previously in
studies of morsellized impacted bone grafts studying
the impact of mechanical load on the graft [10] as well
as using bone morphogenic protein (BMP) in addition
[12]. With a similar SD and the same clinically signifi-
cant difference, we anticipated that we would be able
to reach significance with similar differences and with
the same power. The additional four rabbits were used
for the CT analysis.
The SPSS® Statistics 20 (IBM®, Chicago, IL, USA) was
used for statistical analyses. The Wilcoxon signed-rank
test was used for paired comparison between right and
left sides and the Mann Whitney U test for comparing
groups at 6 and 12 weeks. Results are presented as me-
dian (interquartile range (IQR)).
Results
All rabbits completed the study period. Food intake and
weight bearing gradually normalized in all animals. One
rabbit sustained a patellar subluxation 6 weeks after sur-
gery but ambulated normally and was therefore in-
cluded. One rabbit showed signs of a superficial wound
infection. Infection was present in the side where the
prosthesis was fixed without Cerament™ at the 12-week
group. At the pull-out test, the prosthesis in the infected
side was loose, whereas in the contralateral side, in
which Cerament™ was used, the pull-out force was 227
N. In the test protocol, infection, fracture, and luxation
were defined as a cause for exclusion. Therefore, the
animal was excluded from the study.
Pull-out test
After 6 weeks, no differences in maximum pull-out
force were found between the prostheses fixed with or
without Cerament™ (p = 0.92). However, at 12 weeksH
Figure 4 Histology slides showing the bone integration. Histology slid
Cerament™ (original magnification ×1 (left) and ×20 (right)) in the distal pa
formed bone. NB, new bone; HA, hydroxyapatite particles.the maximum pull-out force for the prostheses fixed
with Cerament™ was significantly higher than that for
the prostheses without Cerament™ (p = 0.04). The max-
imum pull-out force increased between 6 and 12 weeks
in the prostheses fixed with Cerament™ (156 to 256 N;
p = 0.03) but showed no significant difference in
the prosthesis fixed without Cerament™ (143 to 175 N;
p = 0.20) (Table 1).
Histological and histomorphometric findings
The histology after 6 and 12 weeks showed new-formed
bone in both groups. However, differences in bone ir-re-
gularity and thickness were noticed. In the 6-week
group, the arrangement of the bone matrix appeared
slightly disrupted and the surface of the new bone at the
interface toward the prosthesis was coarse. In the 12-
week group, the new-formed bone was smoother and
the bone matrix around the prostheses was more regu-
larly arranged, i.e., more mature (Figure 3). Over weeks,
the calcium sulfate component appeared to have been
replaced by new-formed trabecular bone, which also in-
tegrated with the hydroxyapatite component (Figure 4).
Histology in the rabbit excluded from the study 12
weeks after surgery showed signs of fibrous tissue in the
side where the prosthesis was fixed without Cerament™
and infection was present, and new-formed trabecular
bone which integrated with the hydroxyapatite compo-
nent in the side where Cerament™ was used.
The bone contact was between 60% and 66% both at 6
and 12 weeks independent of the fixation method of the
prosthesis. Hence, the bone contact did not differ bet-
ween the groups with prostheses fixed with or without
Cerament™ at either time point.
Micro-computed tomography
The bone contact was high and the surface was smooth
in both groups both after 6 and 12 weeks (Figure 5). The
BV/TV ranged from 35% to 44% in the region of
interest.A
NB
es showing the bone integration at week 6 in the prosthesis fixed with
rt of the prosthesis. Hydroxyapatite particles surrounded by new-
Figure 5 Micro-CT images. Micro-CT 3D rendering of the proximal tibia (A), and the bone within a 5.5-mm-diameter region (B, C) showing
high bone contact with smooth surface in both groups both after 6 and 12 weeks. BV/TV ranged from 35% to 44% in the region of interest.
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In joint arthroplasty, the role of the bone graft or bone
substitute is different than that in many other situations
like in fracture healing or nonunion treatment. Firstly
and most importantly, the graft should provide mechan-
ical support for the prosthesis, not only during the im-
mediate postoperative period but also during the later
remodeling period. Secondly, it is desirable that the
prosthesis-bone graft interface consists of living bone,
capable of a constant repair due to the accumulated
stress in the supporting bone during loading. Particulate
bone grafts are used to fill voids in primary and revision
arthroplasties. It has been speculated that the reason for
the good long-term results achieved by the use of
morsellized impacted bone graft in revision surgery lies
in it being remodeled more slowly or maybe to a lesser
extent [13,14]. In both animal models [15] as well as in
humans [16], BMP has been tried to enhance remodel-
ing with a less than acceptable result. We know today
that although BMP induces bone formation, it also in-
duces bone resorption through the RANKL system [17].
The resorption can be delayed by using an anti-
resorptive drug like a bisphosphonate [12], which byspeculation also would lead to improved bone quality
also in humans [18].
The advantage of using an injectable bone substitute
encompasses the ability to fill out the entire space be-
tween the prosthesis and the bone, thereby adding to
the primary stability of the prosthesis. In contrast to
PMMA, the bone substitute is bone conductive and the
bone defect is at least theoretically replaced by host
bone. The important factor for the stability during re-
modeling is not only the strength of the material at in-
sertion but rather the speed of resorption and thereby
the strength over time.
In the present study, we used a bone substitute com-
posed of calcium sulfate and hydroxyapatite, which pro-
vides stabilization not only initially but also later during
the period of remodeling and biological stabilization. We
use a primary surgery model and not a revision which is
a limitation of the study and which might influence the
magnitude of pull-out strength. Biologically, the fast re-
sorption of the calcium sulfate is the key feature for later
bone remodeling. The resorption creates space for the in-
growing bone, which in turn is able to integrate with the
nonresorbing hydroxyapatite particles, and hypothetically,
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interface. The biphasic Cerament™ was used in a recent
study of 33 patients who underwent percutaneous ver-
tebroplasty after osteoporotic and/or traumatic vertebral
fractures. Radiological and clinical outcome was assessed
by radiography, CT, and MRI, and 12 months after sur-
gery, the fractures were stabile and new bone formation
visible [19].
In our present animal study, the pull-out force of the
prostheses fixed with Cerament™ increased significantly
between 6 and 12 weeks. At 12 weeks the maximum
pull-out force for the prostheses fixed with Cerament™
was significantly higher than that for the prostheses
without Cerament™. A biological reinforcement of the
fixation by a gradual substitution of the bone substitute
with living bone could be important for long-term fix-
ation. As shown in both histology and micro-CT, the
proportion of living bone at the interface at both 6 and
12 weeks was similar in the two groups, suggesting a
qualitative difference rather than a quantitative one.
Most importantly, no adverse effects were found by the
bone substitute. We believe that Cerament™ can be used
as bone void filler also in prosthetic fixation; however,
further studies are required.Additional files
Additional file 1: The surgical approach and the prosthesis fixation.
(A) Resection of the tibia plate. (B) Preparation of the tibia medullary
canal. (C) Cerament™ fixation. (D) The fixation of the prosthesis on the
tibia plate.
Additional file 2: Pull-out test. The fixed tibia was mounted on an
Instron 8511 load frame with an MTS TestStar II controller.Competing interests
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